CD4 and metabolic dysfunction-associated steatohepatitis: NASH promotes HCC by impairing immune surveillance through the suppression of CD4+ and CD8+ T cells, increasing intestinal inflammation, and disrupting gut microbiota homeostasis—processes that are pivotal in hepatocarcinogenesis (154).